Korean Stem Cell Film Tops Box Office

A movie based on the Woo Suk Hwang cloning scandal is popular in South Korea, but the plotline strays from reality.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Human embryonic stell cell colony on a mouse embryonic fibroblast feeder layerWIKIMEDIA, SREEJITHK2000 The South Korean film Je-bo-ja (Whistleblower), based on the transgressions of disgraced stem cell scientist Woo Suk Hwang, sits atop the country’s box office, raking in more than 4.5 billion South Korean Won (about USD $4.3 million) in its first weekend in theaters. But a key player in the actual events that unfolded in Hwang’s laboratory told Nature that the movie skews several facts.

Young Joon Ryu was the actual whistleblower who first alerted the world to one of the biggest scientific scandals in history: in the mid-2000s, Hwang had faked data and unethically procured oocytes to claim the successful creation of stem-cell lines from cloned human embryos. Ryu said that Whistleblower credits a news reporter character with many of the revelations that he and bloggers brought to light about the scandal. While he said he understood the movie’s focus on “fast action, dramatic conflicts and famous actors,” he told Nature that the film’s truth bending was eerily familiar to what he had experienced in Hwang’s lab.

Director Soon Rye Yim told Nature that his film was not meant to be a faithful retelling of events but rather a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies